Announcements Trials
Browse Landscape

Phase

Phase 4 15Phase 3 10Phase 2 8Phase 1 8Phase EARLY_PHASE1 2Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Dermatologic 1

Conditions

Keratosis, Actinic 1

Interventions

Blood Specimen Collection 16Cyclophosphamide 11fludarabine phosphate 10Peripheral Blood Stem Cell Transplantation 10Cyclosporine 10Photochemotherapy 9Biopsy 9Whole-Body Irradiation 8Standard of Care 8Radiotherapy 8Educational Status 8Surgical Procedures, Operative 7Radiosurgery 7Mycophenolic Acid 7Early Intervention, Educational 7Aminolevulinic Acid 7Tomography, Optical Coherence 6Surveys and Questionnaires 6Psychiatric Rehabilitation 6Practice Guidelines as Topic 6Methods 6Melphalan 6Filgrastim 6Sentinel Lymph Node Biopsy 5Magnetic Resonance Spectroscopy 5Busulfan 5Antilymphocyte Serum 5methyl 5-aminolevulinate 4Therapeutics 4Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Imiquimod × Dermatologic × Clear all
NCT00814528 2018-09-10

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

University of Chicago

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡